0
Lige et link til webcast fra Pdl Biopharma, som jo solgt fabrikken til genmab.
Er der nogen som har kikket nærmere på dem, syntes det ser spænde ud med deres royalty.
Kunne godt tænke mig at høre mening fra nogen af de garvede eksperter her på PI.
http://www.wsw.com/webcast/jmp11/pdli/
Hjemmeside
http://pdl.com/
Er der nogen som har kikket nærmere på dem, syntes det ser spænde ud med deres royalty.
Kunne godt tænke mig at høre mening fra nogen af de garvede eksperter her på PI.
http://www.wsw.com/webcast/jmp11/pdli/
Hjemmeside
http://pdl.com/
27/9 2010 19:36 Franquin 034020 Patentet ser ud til at udløbe i 2014 og dermed også deres royalty. Genmabs antistoffer er en generation nyere (fuldt humane) i forhold til Pdl's.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed today based on patents that expire in late 2014. For more information, please visit www.pdl.com
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed today based on patents that expire in late 2014. For more information, please visit www.pdl.com
